Members of the Board of Directors are organizational stewards who are passionate about endocrine research and practice and are committed to our mission – to unite, lead, and grow the endocrine community to accelerate scientific breakthroughs and improve health worldwide. To learn more about this dynamic group of leaders, please review their bios. If you’d like to become a member leader, learn more today.
President
Stephen R. Hammes, MD, PhD
University of Rochester
Term end: 2025
President-Elect
John Newell-Price, MD, PhD, FRCP
University of Sheffield
Term end: 2026
Secretary/Treasurer
Jeffrey Boord, MD, MPH
Parkview Health
Term end: 2025
Early Career Director
Stanley Andrisse, MBA, PhD
Howard University,
Washington, DC
Term end: 2026
Ricardo Azziz, MD, MBA, MPH
University of Alabama
Birmigham, Alabama
Term end: 2026
Maria Fleseriu, MD
Oregon Health & Science University
Portland, OR
Term end: 2026
Andrea C. Gore, PhD
The University of Texas at Austin
Term end: 2025
Arthur Gutierrez-Hartmann, MD
University of Colorado Anschutz Medical Campus (Retired)
Term end: 2024
Karen SL Lam, MBBS, MD, DSc
The University of Hong Kong
Term end: 2025
Barbara Onumah, MD
Anne Arundel Medical Center Diabetes and Endocrine Specialists
Term end: 2025
Rocio Pereira, MD
Denver Health Medical Center
Term end: 2024
Bu Yeap, MBBS, FRACP, PhD
University of Western Australia
Crawley, Australia
Term end: 2026
Ex-Officio, Nominating Committee Chair
Cecilia Low Wang, MD
University of Colorado Anschutz Medical Campus School of Medicine
Term end: 2024
Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.
Immediate Past President
